A5071668877- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
- Cardiac Imaging and Diagnostics
- Coronary Interventions and Diagnostics
- Cardiac pacing and defibrillation studies
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Ischemia and Reperfusion
- Cardiovascular Function and Risk Factors
- Venous Thromboembolism Diagnosis and Management
- Acute Myocardial Infarction Research
- Lipoproteins and Cardiovascular Health
- Liver Disease Diagnosis and Treatment
- Kawasaki Disease and Coronary Complications
- Vascular Procedures and Complications
- Aortic aneurysm repair treatments
- Cardiovascular Disease and Adiposity
- Cardiac Arrest and Resuscitation
- Biomarkers in Disease Mechanisms
- Acute Kidney Injury Research
- Cardiac Valve Diseases and Treatments
- Cardiovascular Health and Disease Prevention
- Blood Pressure and Hypertension Studies
- Anesthesia and Neurotoxicity Research
- Blood Coagulation and Thrombosis Mechanisms
Hellenic Red Cross
2014-2024
Red Cross Hospital
2014-2024
IASO General Hospital
2023
Hygeia Hospital
2018-2021
National and Kapodistrian University of Athens
2014-2020
BioClinicum (Russia)
2020
Athens Euroclinic
2009-2018
Michigan Medicine
2015-2018
Harvard University
2015-2018
Brigham and Women's Hospital
2016-2018
To conduct a randomized trial in order to guide the optimum therapy of symptomatic atrioventricular nodal re-entrant tachycardia (AVNRT). Patients with at least one episode per month and an electrophysiologic diagnosis AVNRT were randomly assigned catheter ablation or chronic antiarrhythmic drug (AAD) bisoprolol (5 mg od) and/or diltiazem (120–300 od). All patients properly educated treat subsequent episodes autonomic manoeuvres 'pill pocket' approach. The primary endpoint study was hospital...
Because of its low prevalence, data on atypical atrioventricular nodal reentrant tachycardia (AVNRT) are scarce, and the optimal ablation method has not been established. Our study aimed at assessing efficacy safety conventional slow pathway ablation, as applied for typical cases, in AVNRT.We studied 2079 patients with AVNRT subjected to ablation. In 113 patients, mean age 48.5±18.1 years, 68 female, or coexistent without other concomitant arrhythmia was diagnosed. Ablation outcomes were...
Immunohistochemistry studies suggest that the anatomic substrate of slow pathway in atrioventricular nodal reentrant tachycardia (AVNRT) is left inferior extension. We hypothesized ablation from septum an effective alternative to right-sided ablation.We analyzed our databases AVNRT search cases had used because failure right septal ablation, and then prospectively subjected consenting patients a septal-only procedure. Of 1342 for AVNRT, 15 patients, 11 with typical 4 atypical approach after...
OBJECTIVES To compare serum adiponectin and tumor necrosis factor (TNF)-α among patients with viral liver diseases; to investigate associations of TNF-α histological or characteristics chronic hepatitis C (CHC); alterations during interferon (IFN)-α treatment; assess the relationship between response rates treatment. METHODS Adiponectin (μg/mL) (pg/mL) determinations by enzyme-linked immunosorbent assay (ELISA) in serial samples (before, middle, end, 6 months after end treatment) from 83 CHC...
Background— There is evidence that atypical fast–slow and typical atrioventricular nodal re-entrant tachycardia (AVNRT) do not use the same limb for fast conduction, but no data exist on patients who have presented with both forms of this tachycardia. We compared conduction intervals during AVNRT occurred in patient. Methods Results— In 20 1299 AVNRT, were induced at electrophysiology study by pacing maneuvers autonomic stimulation or spontaneously. The mean age was 47.6±10.9 years (range,...
The exact circuit of atrioventricular nodal re-entrant tachycardia (AVNRT) remains elusive. To assess the location and dimensions AVNRT circuit.Both typical atypical were induced at electrophysiology study 14 patients. We calculated activation time fast slow pathways, consequently, length pathway, by assuming an average conduction velocity 0.04 mm/ms in area. distance between compact node pathway ablating electrode was measured on three-dimensionally reconstructed fluoroscopic images...